Articles

Cutaneous squamous-cell carcinoma (CSCC) is a type of nonmelanoma skin cancer that affects the squamous cells in the middle and outer layers of the skin.
Hairy-cell leukemia (HCL) is a rare and indolent hematologic cancer. HCL, which is 4 to 5 times more frequent in men than in women, accounts for 2% of all leukemias.
Community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) are serious and potentially life-threatening infections. Bacteria can mutate, resulting in antibiotic-resistant infections, which is a major health concern that affects more than 2 million Americans and causes 23,000 deaths annually
Rheumatoid arthritis is a chronic inflammatory autoimmune disease that affects approximately 1.5 million people in the United States and is nearly 3 times more common in women than in men.
Acute myeloid leukemia (AML) is a rare but deadly cancer. In 2018, approximately 19,500 new cases of AML were estimated to be diagnosed in the United States and more than 10,600 people to die from the disease.
It is estimated that 39 million individuals in the United States, approximately 12% of the population, were affected by migraine headache in 2018.
Febrile neutropenia is a serious complication of cancer chemotherapy that can require treatment delays and chemotherapy dose reductions, which compromise the efficacy of treatment
Gene mutations or rearrangements in the tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are emerging as an important driver of cancer-cell growth in a wide range of cancer.
Ulcerative colitis is an inflammatory bowel disease that causes chronic inflammation of the digestive tract and affects an estimated 907,000 individuals in the United States.
On April 4, 2019, the US Food and Drug Administration (FDA) expanded the indication of palbociclib (Ibrance; Pfizer), a kinase inhibitor, in combination with specific endocrine therapies for men with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. This is the first hormonal-based therapy to be approved for men.
Page 4 of 194
Results 31 - 40 of 1934
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME